Posted by Michael Wonder on 13 Jun 2022
SMC - June 2022 decisions
13 June 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today published advice on four new medicines.
Relugolix combination therapy (Ryeqo, which combines the medicines relugolix, estradiol and norethisterone acetate) was accepted for the treatment of moderate to severe symptoms from uterine fibroids in adult women of reproductive age.
